Portfolio companies.
34,000+ PE-backed.

Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.

Active deals

currently held

Exits tracked

hand-checked

Sectors covered

across the portfolio

Countries covered

from every market

Latest activityLast event 2026-09-23

Caledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week ago

Caledonia Investments1 week ago

Capital Event · capital-cancellation-shares · Capital structure change

capital

Caledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week ago

Caledonia Investments1 week ago

Capital Event · capital-cancellation-shares · Capital structure change

capital

Caledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week ago

Caledonia Investments1 week ago

Capital Event · capital-cancellation-shares · Capital structure change

capital

Elaia PartnersadminCEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway2 weeks ago

Elaia Partners2 weeks ago

CEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway

admin

Lauxera Capital PartnersadminBoard change · Management board member change: et Directeur général délégué Fracchia, Edoardo · Change in the management board1 month ago

Company	Sector	Geo	Investor	Entry	Hold	Status	Buyer	MOIC
Allderma 3iM Equity Partners	Pharma	Sweden	3iM	2020	6yr	Exited 2026	Avia Pharma (Impilo)	–
Cinclus Pharma3 periods Claret European Growth Capital Fund IV	Pharma	Sweden	Claret Capital Partners	2022	2yr	Active	–	–
Ascelia Pharma Sunstone Life Science Ventures III	Pharma	Sweden	Sunstone Life Science Ventures	2008	11yr	Exited 2019	–	–
Wilson Therapeutics AB HealthCap VI	Pharma	Sweden	HealthCap	2012	6yr	Exited 2018	Alexion Pharmaceuticals	–
Karo Pharma (Karo Bio) HealthCap (early funds)	Pharma	Sweden	HealthCap	1996	2yr	Exited 1998	–	–
Recipharm3 periods CM-CIC Debt Fund 3	Pharma	Sweden	CIC Private Debt	2021	5yr	Active	–	–
Abarceo Pharma Almi Invest (Regional funds)	Pharma	Sweden	Almi Invest	2021	5yr	Active	–	–
Akinion Pharmaceuticals Rosetta Capital IV	Pharma	Sweden	Rosetta Capital	2013	13yr	Active	–	–
Artroa AB SLU Holding	Pharma	Sweden	SLU Holding	2023	3yr	Active	–	–
Avia Pharma Impilo Investment Pool 2	Pharma	Sweden	Impilo	2024	2yr	Active	–	–
Bohus Biotech Flerie Invest	Pharma	Sweden	Flerie	2022	4yr	Active	–	–
FrostPharma Priveq Investment VI	Pharma	Sweden	Priveq	2023	3yr	Active	–	–
Immedica Impilo Investment Pool 1	Pharma	Sweden	Impilo	2018	8yr	Active	–	–
Medovia Novax	Pharma	Sweden	Novax	2015	11yr	Active	–	–
MyCural Therapeutics AB SLU Holding	Pharma	Sweden	SLU Holding	2022	4yr	Active	–	–
NorthX Biologics Flerie Invest	Pharma	Sweden	Flerie	2021	5yr	Active	–	–
Orexo Novo Holdings Growth Investments	Pharma	Sweden	Novo Holdings	2010	16yr	Active	–	–
Pelago Bioscience Impilo Investment Pool 2	Pharma	Sweden	Impilo	2023	3yr	Active	–	–
Prolevi Bio Almi Invest (Regional funds)	Pharma	Sweden	Almi Invest	2022	4yr	Active	–	–
Purpose Pharma Eir Ventures I	Pharma	Sweden	Eir Ventures	2024	2yr	Active	–	–
Sobrera Pharma GU Ventures Evergreen	Pharma	Sweden	GU Ventures	2019	7yr	Active	–	–
Strike Pharma AB SLU Holding	Pharma	Sweden	SLU Holding	2021	5yr	Active	–	–
Veltio Pharma Almi Invest (Regional funds)	Pharma	Sweden	Almi Invest	2022	4yr	Active	–	–
Vicore Pharma HealthCap VII	Pharma	Sweden	HealthCap	2018	8yr	Active	–	–
Xspray Pharma Flerie Invest	Pharma	Sweden	Flerie	2021	5yr	Active	–	–

Portfolio companies.34,000+ PE-backed.

Portfolio companies.
34,000+ PE-backed.